Novel human interleukin-2 polypeptide derivative
    3.
    发明授权
    Novel human interleukin-2 polypeptide derivative 失效
    新型人白介素-2多肽衍生物

    公开(公告)号:US4851512A

    公开(公告)日:1989-07-25

    申请号:US911811

    申请日:1986-09-26

    CPC分类号: C07K14/55 Y10S930/141

    摘要: Novel human IL-2 polypeptide derivatives characterized by deletion of at least one amino acid from the amino acid sequence of the human IL-2 polypeptide, recombinant plasmids containing DNAs coding for the above derivatives, microorganisms harboring these plasmids and methods of producing the above derivatives in these microorganisms are provided.

    摘要翻译: 新型人IL-2多肽衍生物,其特征在于从人IL-2多肽的氨基酸序列缺失至少一个氨基酸,含有编码上述衍生物的DNA的重组质粒,携带这些质粒的微生物和产生上述衍生物的方法 提供这些微生物。

    Preventive and/or therapeutic drugs for asthma
    9.
    发明申请
    Preventive and/or therapeutic drugs for asthma 审中-公开
    用于哮喘的预防和/或治疗药物

    公开(公告)号:US20060239999A1

    公开(公告)日:2006-10-26

    申请号:US10525326

    申请日:2003-08-22

    摘要: The present invention provides an agent for prevention and/or treatment of asthma comprising a substance capable of suppressing the function involved in signal transduction of GPR4 as an active ingredient. It also provides an agent for prevention and/or treatment of asthma which comprises a nitrogen-containing tricyclic compound represented by the formula (I) or a quaternary ammonium salt thereof, or a pharmaceutically acceptable salt thereof; [wherein R1 represents a substituted or unsubstituted lower alkyl, or the like; R2 represents hydrogen, a substituted or unsubstituted lower alkyl, or the like; R3 and R4 are the same or different and each represents hydrogen, lower alkyl, or the like; n represents 0 or 1; X represents —(CH2)2—, or the like; and Y represents the formula (II) (wherein W represents CH or a nitrogen atom; Z1 and Z2 are the same or different and each represents hydrogen, a substituted or unsubstituted lower alkyl, or the like; and Z3 represents hydrogen, a substituted or unsubstituted lower alkyl, or the like)] as an active ingredient.

    摘要翻译: 本发明提供了用于预防和/或治疗哮喘的药剂,其包含能够抑制作为活性成分的GPR4的信号转导所涉及的功能的物质。 它还提供了一种预防和/或治疗哮喘的药剂,其包含由式(I)表示的含氮三环化合物或其季铵盐或其药学上可接受的盐; [其中R 1表示取代或未取代的低级烷基等; R 2表示氢,取代或未取代的低级烷基等; R 3和R 4相同或不同,各自表示氢,低级烷基等; n表示0或1; X表示 - (CH 2 2)2 - 等; Y表示式(II)(其中W表示CH或氮原子; Z 1和Z 2相同或不同,各自表示氢,取代或 未取代的低级烷基等; Z 3表示氢,取代或未取代的低级烷基等)作为活性成分。